1. Home
  2. NEPH vs ALUR Comparison

NEPH vs ALUR Comparison

Compare NEPH & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • ALUR
  • Stock Information
  • Founded
  • NEPH 1997
  • ALUR 2009
  • Country
  • NEPH United States
  • ALUR United States
  • Employees
  • NEPH N/A
  • ALUR N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • ALUR
  • Sector
  • NEPH Health Care
  • ALUR
  • Exchange
  • NEPH Nasdaq
  • ALUR Nasdaq
  • Market Cap
  • NEPH 16.8M
  • ALUR 14.2M
  • IPO Year
  • NEPH 2004
  • ALUR N/A
  • Fundamental
  • Price
  • NEPH $2.09
  • ALUR $2.80
  • Analyst Decision
  • NEPH Buy
  • ALUR Strong Buy
  • Analyst Count
  • NEPH 1
  • ALUR 3
  • Target Price
  • NEPH $5.00
  • ALUR $22.83
  • AVG Volume (30 Days)
  • NEPH 7.3K
  • ALUR 568.1K
  • Earning Date
  • NEPH 05-08-2025
  • ALUR 05-14-2025
  • Dividend Yield
  • NEPH N/A
  • ALUR N/A
  • EPS Growth
  • NEPH N/A
  • ALUR N/A
  • EPS
  • NEPH 0.08
  • ALUR N/A
  • Revenue
  • NEPH $15,517,000.00
  • ALUR $28,304,000.00
  • Revenue This Year
  • NEPH $9.23
  • ALUR N/A
  • Revenue Next Year
  • NEPH $12.99
  • ALUR $38.86
  • P/E Ratio
  • NEPH $28.58
  • ALUR N/A
  • Revenue Growth
  • NEPH 10.34
  • ALUR N/A
  • 52 Week Low
  • NEPH $1.36
  • ALUR $2.15
  • 52 Week High
  • NEPH $2.55
  • ALUR $88.75
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 57.94
  • ALUR 64.86
  • Support Level
  • NEPH $1.88
  • ALUR $2.15
  • Resistance Level
  • NEPH $2.23
  • ALUR $2.41
  • Average True Range (ATR)
  • NEPH 0.17
  • ALUR 0.21
  • MACD
  • NEPH 0.01
  • ALUR 0.07
  • Stochastic Oscillator
  • NEPH 69.23
  • ALUR 60.63

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Share on Social Networks: